UBS Group’s Cardiff Oncology CRDF Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $622K | Buy |
197,438
+110,903
| +128% | +$349K | ﹤0.01% | 4690 |
|
2025
Q1 | $272K | Sell |
86,535
-196,817
| -69% | -$618K | ﹤0.01% | 5101 |
|
2024
Q4 | $1.23M | Buy |
283,352
+234,788
| +483% | +$1.02M | ﹤0.01% | 4078 |
|
2024
Q3 | $130K | Buy |
48,564
+6,599
| +16% | +$17.6K | ﹤0.01% | 4990 |
|
2024
Q2 | $93.2K | Buy |
41,965
+39,003
| +1,317% | +$86.6K | ﹤0.01% | 5077 |
|
2024
Q1 | $15.8K | Sell |
2,962
-393
| -12% | -$2.1K | ﹤0.01% | 5856 |
|
2023
Q4 | $4.97K | Buy |
3,355
+3,292
| +5,225% | +$4.87K | ﹤0.01% | 6601 |
|
2023
Q3 | $88 | Sell |
63
-3,751
| -98% | -$5.24K | ﹤0.01% | 7765 |
|
2023
Q2 | $5.61K | Sell |
3,814
-11,876
| -76% | -$17.5K | ﹤0.01% | 6354 |
|
2023
Q1 | $25.9K | Buy |
15,690
+10,005
| +176% | +$16.5K | ﹤0.01% | 5804 |
|
2022
Q4 | $7.96K | Sell |
5,685
-2,760
| -33% | -$3.86K | ﹤0.01% | 7645 |
|
2022
Q3 | $13K | Buy |
8,445
+8,403
| +20,007% | +$12.9K | ﹤0.01% | 6914 |
|
2022
Q2 | $0 | Sell |
42
-6,942
| -99% | – | ﹤0.01% | 9304 |
|
2022
Q1 | $17K | Sell |
6,984
-5,080
| -42% | -$12.4K | ﹤0.01% | 6595 |
|
2021
Q4 | $72K | Buy |
12,064
+8,704
| +259% | +$51.9K | ﹤0.01% | 5502 |
|
2021
Q3 | $22K | Buy |
+3,360
| New | +$22K | ﹤0.01% | 5919 |
|
2021
Q1 | – | Sell |
-634
| Closed | -$11K | – | 7945 |
|
2020
Q4 | $11K | Sell |
634
-3,145
| -83% | -$54.6K | ﹤0.01% | 6375 |
|
2020
Q3 | $53K | Sell |
3,779
-743
| -16% | -$10.4K | ﹤0.01% | 4751 |
|
2020
Q2 | $23K | Sell |
4,522
-5,088
| -53% | -$25.9K | ﹤0.01% | 5612 |
|
2020
Q1 | $9K | Buy |
9,610
+7,213
| +301% | +$6.76K | ﹤0.01% | 6067 |
|
2019
Q4 | $3K | Sell |
2,397
-5,310
| -69% | -$6.65K | ﹤0.01% | 6658 |
|
2019
Q3 | $12K | Buy |
7,707
+2,939
| +62% | +$4.58K | ﹤0.01% | 6079 |
|
2019
Q2 | $12K | Buy |
4,768
+3,974
| +501% | +$10K | ﹤0.01% | 6062 |
|
2019
Q1 | $3K | Sell |
794
-38,920
| -98% | -$147K | ﹤0.01% | 6490 |
|
2018
Q4 | $21K | Buy |
39,714
+21,561
| +119% | +$11.4K | ﹤0.01% | 5822 |
|
2018
Q3 | $15K | Buy |
18,153
+3,717
| +26% | +$3.07K | ﹤0.01% | 6038 |
|
2018
Q2 | $11K | Sell |
14,436
-7,564
| -34% | -$5.76K | ﹤0.01% | 6146 |
|
2018
Q1 | $8K | Buy |
22,000
+8,300
| +61% | +$3.02K | ﹤0.01% | 6107 |
|
2017
Q4 | $4K | Sell |
13,700
-18,744
| -58% | -$5.47K | ﹤0.01% | 6477 |
|
2017
Q3 | $24K | Buy |
32,444
+21,065
| +185% | +$15.6K | ﹤0.01% | 5421 |
|
2017
Q2 | $14K | Sell |
11,379
-2,446
| -18% | -$3.01K | ﹤0.01% | 5592 |
|
2017
Q1 | $16K | Sell |
13,825
-19,822
| -59% | -$22.9K | ﹤0.01% | 5382 |
|
2016
Q4 | $71K | Buy |
33,647
+23,480
| +231% | +$49.5K | ﹤0.01% | 4656 |
|
2016
Q3 | $46K | Sell |
10,167
-1,400
| -12% | -$6.33K | ﹤0.01% | 4720 |
|
2016
Q2 | $53K | Buy |
11,567
+3,217
| +39% | +$14.7K | ﹤0.01% | 4623 |
|
2016
Q1 | $39K | Buy |
8,350
+785
| +10% | +$3.67K | ﹤0.01% | 4880 |
|
2015
Q4 | $41K | Buy |
7,565
+2,065
| +38% | +$11.2K | ﹤0.01% | 4902 |
|
2015
Q3 | $31K | Buy |
5,500
+400
| +8% | +$2.26K | ﹤0.01% | 5066 |
|
2015
Q2 | $52K | Sell |
5,100
-33,905
| -87% | -$346K | ﹤0.01% | 4755 |
|
2015
Q1 | $266K | Buy |
39,005
+22,672
| +139% | +$155K | ﹤0.01% | 3613 |
|
2014
Q4 | $71K | Buy |
+16,333
| New | +$71K | ﹤0.01% | 4447 |
|